24.19
0.12 (0.50%)
| Penutupan Terdahulu | 24.07 |
| Buka | 24.74 |
| Jumlah Dagangan | 552,877 |
| Purata Dagangan (3B) | 634,377 |
| Modal Pasaran | 1,086,922,496 |
| Harga / Pendapatan (P/E TTM) | 51.47 |
| Harga / Pendapatan (P/E Ke hadapan) | 7.36 |
| Harga / Jualan (P/S) | 1.53 |
| Harga / Buku (P/B) | 1.42 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -14.76% |
| Margin Operasi (TTM) | 4.63% |
| EPS Cair (TTM) | -2.24 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 1.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -46.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 79.70% |
| Nisbah Semasa (MRQ) | 2.41 |
| Aliran Tunai Operasi (OCF TTM) | 175.75 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 144.75 M |
| Pulangan Atas Aset (ROA TTM) | 3.56% |
| Pulangan Atas Ekuiti (ROE TTM) | -12.27% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menaik | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menaik | Bercampur | |
| Stok | Pacira BioSciences, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 1.00 |
|
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.79% |
| % Dimiliki oleh Institusi | 110.89% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 38.00 (HC Wainwright & Co., 57.09%) | Beli |
| Median | 33.00 (36.42%) | |
| Rendah | 28.00 (Truist Securities, 15.75%) | Beli |
| Purata | 33.00 (36.42%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 22.97 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 17 Nov 2025 | 38.00 (57.09%) | Beli | 23.88 |
| Truist Securities | 07 Nov 2025 | 28.00 (15.75%) | Beli | 22.05 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |